Panel Discussion: The Challenges to Clinical Biostatistics Modernization

Pharmaceutical companies and contract research organizations have made and continue to make significant investments to modernize their biostatistics functions, collectively through cross-industry collaborations, and individually through internal technology refresh projects. Although there has been progress, much more is needed for true benefits to be achieved. This panel discussion will examine the challenges and obstacles that slow progress and prolong time to benefit realization.

Panelists:
Caroline Phares | Vice President, Healthcare and Life Sciences, Altair
Michael Rimler | PHUSE Open Source Technologies Director and Pharmaverse Council Member for GSK
Bhavin Busa | Principal & Co-Founder, Clymb Clinical
Stuart Malcolm | Head of Standards, Efficiency, and Automation at Veramed

Presented as part of Altair's Future.Industry 2024 conference.

Please note that presentations are in English by default. The following languages are available by clicking on Audio Description AD)) on screen: DE, ES, FR, IT, JA, KO , PT, ZH-CN.

Duration: 31 minutes